SANTA CLARA, CA, UNITED STATES, January 20, 2026 /EINPresswire.com/ -- OmicInsight Corporation, an innovator in ...
TOKYO, JAPAN, January 14, 2026 / EINPresswire.com / — LOTTE Holdings, Co., Ltd. (Tokyo, Japan; CEO: Genichi Tamatsuka, ...
Vizgen, Inc., a spatial multi-omics innovator accelerating biological discovery and new drug development, today announced that it will present new spatial multi-omics data at the Society for ...
There’s a lot scientists don’t know about the thousands of proteins in the human body, and protein sequences don’t tell the full story. “I'm interested in how much biological information is spatially ...
Metformin is a widely used first-line therapy for type 2 diabetes, and studies increasingly point to its protective effects on the kidney. However, the mechanisms underlying metformin’s renal benefits ...
Renowned vision researcher Dr. Rui Chen to apply 3D spatial multi-omics for mapping sensory systems and advancing Human Cell Atlas discoveries BOSTON, Dec. 3, 2025 /PRNewswire/ -- Stellaromics, a ...
WALTHAM, Mass.--(BUSINESS WIRE)--Vizgen, Inc., a leader in spatial multi-omics, today announced the closing of a $48 million financing. The financing was led by ARCH Venture Partners and co-led by M ...
AZoLifeSciences on MSN
Life science and biotech trends for 2026
Advancements in AI, multi-omics, and genome editing are transforming life sciences and biotechnology, addressing new ...
Type 2 diabetes (T2D) is a major chronic metabolic disease worldwide and is especially prevalent in older adults. Although many synthetic drugs are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results